Female (3,708); Male (3,903); Unknown (95)

0 to 4 years (1,747); 5 to 9 years (1,689); 10 to 14 years (1,608); 15 to 19 years (1,063); 20 to 24 years (252); 25 to 29 years (80); 30 to 34 years (30); 35 to 39 years (20); Pediatric and Young Adult (<40 years) (1,217)

American Indian or Alaska Native (27); Asian (194); Black or African American (437); More Than One Race (40); Native Hawaiian or Other Pacific Islander (27); Other (18); White (3,224); Not Reported (3,739)

Hispanic or Latino (677); Not Hispanic or Latino (3,837); Not Reported (3,192)

Adamantinomatous Craniopharyngioma (8); Astrocytoma, IDH-Mutant (5); Atypical Choroid Plexus Papilloma (3); Atypical Meningioma (2); Atypical Teratoid/Rhabdoid Tumor (135); Central Nervous System Embryonal Tumor (110); Central Nervous System Germ Cell Tumor (49); Central Nervous System Germinoma (73); Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma (1); Central Nervous System Melanocytic Neoplasm (1); Central Nervous System Nongerminomatous Germ Cell Tumor (35); Central Nervous System Sarcoma (48); Central Neurocytoma (11); Chordoma (16); Choroid Plexus Carcinoma (38); Choroid Plexus Papilloma (77); CIC-Rearranged Sarcoma (2); Craniopharyngioma (175); Diffuse Hemispheric Glioma, H3 G34-Mutant (3); Diffuse Leptomeningeal Glioneuronal Tumor (1); Diffuse Low Grade Glioma, MAPK Pathway-Altered (1); Diffuse Midline Glioma, H3 K27-Altered (5); Diffuse Pediatric-Type High Grade Glioma, H3-Wildtype and IDH-Wildtype (2); Dysembryoplastic Neuroepithelial Tumor (110); Embryonal Tumor with Multilayered Rosettes (22); Embryonal Tumor with Multilayered Rosettes, C19MC-Altered (2); Ependymoma (398); Ewing Sarcoma (26); Extraventricular Neurocytoma (1); Ganglioglioma (232); Glioblastoma, IDH-Wildtype (1); Glioneuronal and Neuronal Tumors (92); Hemangioblastoma (22); High Grade Astrocytoma with Piloid Features (2); Histiocytic Sarcoma (1); Infant-Type Hemispheric Glioma (1); Juvenile Xanthogranuloma (2); Langerhans Cell Histiocytosis (18); Low Grade Glioma (1,444); Malignant Glioma (833); Malignant Melanotic Peripheral Nerve Sheath Tumor (1); Malignant Peripheral Nerve Sheath Tumor (1); Medulloblastoma (592); Medulloblastoma, Non-WNT/Non-SHH (30); Medulloblastoma, Non-WNT/Non-SHH, Group 3 (7); Medulloblastoma, Non-WNT/Non-SHH, Group 4 (6); Medulloblastoma, WNT-Activated (5); Meningioma (126); Myxopapillary Ependymoma (2); Neurofibroma (5); Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted (2); Papillary Glioneuronal Tumor (1); Pilocytic Astrocytoma (52); Pineoblastoma (39); Pineocytoma (1); Pituitary Neuroendocrine Tumor (40); Pleomorphic Xanthoastrocytoma (7); Polymorphous Low Grade Neuroepithelial Tumor of the Young (1); Posterior Fossa Ependymoma (2); Posterior Fossa Ependymoma, Group A (6); Posterior Fossa Ependymoma, Group B (3); Rhabdomyosarcoma (9); Rosette-Forming Glioneuronal Tumor (2); Schwannoma (119); Subependymal Giant Cell Astrocytoma (17); Subependymoma (2); Supratentorial Ependymoma (2); Not Reported (2,618)

Yes (5,662); No (2,044)

miRNA Sequencing (22); RNA Sequencing (2,206); Whole Genome Sequencing (6,094)